Press Releases and News
BPS18 was the 62nd annual meeting for the Biophysical Society, one of the largest gathering of biophysicists in the world. There were more than 7,000 researchers from over 45 countries in attendance. The event is focused on the professional development of biophysicists, so there was a real interest in learning about new techniques for protein … “Biophysical Society: educating biophysicists on cutting edge technologies in protein characterization”
PepTalk: The Protein Science Week is one of the largest annual gatherings of protein science researchers in the world. The RedShiftBio team attended in January to present a poster on Thermal Denaturation Analysis of Bovine Serum Albumin by Microfluidic Modulation Spectroscopy. We got to meet with many of the nearly 1,300 experts from academia, biotech … “Celebrating new analytical techniques to accelerate the development of life saving biotherapeutics at PepTalk”
RedShift BioAnalytics, Inc., an innovative provider of bioanalytical instrumentation for the research, development and manufacturing of protein therapeutic drugs, recently announced the hiring of Jeffrey Zonderman as Chief Commercial Officer.
RedShift Bioanalytics (RedShiftBio) appoints new European Director for Sales and Support and East Coast Regional Sales Manager to help satisfy demand for its award-winning protein characterization system.
RedShift BioAnalytics, Inc., an innovative provider of bioanalytical instrumentation for the research, development and manufacturing of protein therapeutic drugs, today announced the closing of the Company’s $11.0 million Series C Preferred Stock financing.